Technology
技术平台
技术平台

Literature Express | High-scoring SCI Article (IF Value: 26.8) Biomimetic Urethra-on-a-Chip Platform for Modelling Fibrosis: 3D-Printing and Near-Field Electrospinning in BAM-Functionalized Microenvironment


High-scoring literature express


Client unit: The Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine


journal:Advanced Materialsr


impact factor(IF):26.8

文章题目:

Biomimetic Urethra-on-a-Chip Platform for Modelling Fibrosis: 3D-Printing and Near-Field Electrospinning in BAM-Functionalized Microenvironment

Urethral stricture, a prevalent urological disorder characterized by fibrosis of periurethral tissues, severely compromises urinary function and patient quality of life. Despite various clinical interventions, recurrence remains frequent, largely due to the lack of physiologically relevant in vitro models for mechanistic investigation and drug screening. Here, we present a biomimetic urethra-on-a-chip platform that integrates microfluidics, three-dimensional (3D) printing, and near-field electrospinning to recapitulate the structural and biochemical complexity of the native urethra. The device features polydimethylsiloxane (PDMS) microchannels coupled with a multilayered polycaprolactone (PCL) membrane, functionalized using a bladder acellular matrix (BAM)–gelatin bioink to emulate the extracellular matrix (ECM) microenvironment. A bilayer microchamber configuration supports spatially organized coculture of fibroblasts and urothelial cells under dynamic perfusion, reproducing physiological shear stress and nutrient gradients. Under fibrotic stimulation by transforming growth factor beta 1 (TGF-β1), the system faithfully mimicked fibroblast activation and epithelial injury, while rapamycin treatment effectively attenuated fibrotic responses, validating its potential for pharmacological testing. This urethra-on-a-chip provides a robust, reproducible, and cost-efficient platform for modeling urethral fibrosis and evaluating antifibrotic therapeutics. By bridging biofabrication, microfluidics, and tissue pathophysiology, this work establishes a versatile organ-on-a-chip model with significant implications for translational research and personalized regenerative medicine.

Original link:

http://doi.org/10.1002/adma.202521431

Reference product and cultured cells: FBS-300 fibroblasts


Recommend
×
Add WeChat friend to learn more about products

Click to copy WeChat ID

微信号:jykppscb888

Replicating Success
wechat number:jykppscb888
Add WeChat friend to learn more about products
Go to WeChat to add friends
语言·Language

语言
Language

请选择 | Please select:
中文中文 | EnglishEnglish

Phone

+86 400 880 5811

WeChat

二维码Scan to follow
TOP